QC
ARNA

QCM Cayman’s Arena Pharmaceuticals Inc ARNA Stock Holding History

QCM Cayman’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,484
Closed -$69K – 307
2015
Q2 		$69K Buy
+1,484
New +$64.4K 0.03% 159

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QCM Cayman's ARNA Position: Q3 2015 in Review

QCM Cayman sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2015, closing a stake of 1,484 shares — an estimated $69K sold.

QCM Cayman first reported a position in ARNA in Q2 2015 and held it in 1 quarter. The position peaked at $69K in Q2 2015. 120 funds tracked by Wall St. Rank hold ARNA as of Q3 2015.

  • QCM Cayman reported no remaining Arena Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • QCM Cayman sold 1,484 Arena Pharmaceuticals Inc shares in Q3 2015, an estimated $69K.
  • QCM Cayman first reported a position in Arena Pharmaceuticals Inc in Q2 2015 and held it in 1 quarter.
  • QCM Cayman's Arena Pharmaceuticals Inc position peaked at $69K in Q2 2015.
  • 120 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2015.

Based on QCM Cayman's 13F filing for Q3 2015, filed 16 Nov 2015.